Magnasium-sparing diuretics: Aldosterone antagonists

Trpm7 2111

only pubmed

16473957 2006. Cardiac fibrogenesis in magnesium deficiency: a role for circulating angiotensin II and aldosterone.
23152295 2013. Calcium reabsorption in the distal tubule: regulation by sodium, pH, and flow.
21653632 2011. Expression of renal distal tubule transporters TRPM6 and NCC in a rat model of cyclosporine nephrotoxicity and effect of EGF treatment.
21270092 2011. Recent advances in distal tubular potassium handling.
18784260 2008. Salt and acid-base metabolism in claudin-16 knockdown mice: impact for the pathophysiology of FHHNC patients.
11704566 2001. Adenosine modulates Mg(2+) uptake in distal convoluted tubule cells via A(1) and A(2) purinoceptors.
11097631 2000. beta-Adrenergic agonists stimulate Mg(2+) uptake in mouse distal convoluted tubule cells.
5645695 1968. Serum magnesium level in the salt-losing type of congenital adrenal hyperplasia.
32631286 2020. Markers of potassium homeostasis in salt losing tubulopathies- associations with hyperaldosteronism and hypomagnesemia.
8485017 1993. A comparison of the potassium and magnesium-sparing properties of amiloride and spironolactone in diuretic-treated normal subjects.
8968545 1996. Endothelin-1-induced contraction in isolated aortae from normotensive and DOCA-salt hypertensive rats: effect of magnesium.
6652361 1983. Evidence for a magnesium-sparing action by amiloride during renal clearance studies in rats.
630331 1978. Magnesium-saving property of an aldosterone antagonist in the treatment of oedema of liver cirrhosis.
5071700 1972. Magnesium deficiency in patients on long-term diuretic therapy for heart failure.
14063033 1963. ALDOSTERONE SECRETION IN MAGNESIUM DEFICIENCY.
14111713 1964. CONTRACTION OF VASCULAR SMOOTH MUSCLE.
7786835 1995. "Escape" of aldosterone production in patients with left ventricular dysfunction treated with an angiotensin converting enzyme inhibitor: implications for therapy.
23838006 2013. Aldosterone signaling through transient receptor potential melastatin 7 cation channel (TRPM7) and its alpha-kinase domain.
14576195 2003. Aldosteronism and peripheral blood mononuclear cell activation: a neuroendocrine-immune interface.
29352074 2018. Aldosterone, SGK1, and ion channels in the kidney.
25589264 2015. Distal convoluted tubule.
20601877 2010. Regulation and function of potassium channels in aldosterone-sensitive distal nephron.
23250359 2013. Angiotensin 1-7 as means to prevent the metabolic syndrome: lessons from the fructose-fed rat model.
604188 1977. Potassium and magnesium depletion in patients with cirrhosis on maintenance diuretic regimens.
25820346 2015. Acid-base and electrolyte abnormalities in heart failure: pathophysiology and implications.
29891771 2018. Role of Magnesium Deficiency in Promoting Atherosclerosis, Endothelial Dysfunction, and Arterial Stiffening as Risk Factors for Hypertension.
15992648 2005. Diuretics and bone loss in rats with aldosteronism.
15364336 2004. Furosemide and the progression of left ventricular dysfunction in experimental heart failure.
24948743 2015. Claudins and the kidney.
25012174 2015. Indomethacin, amiloride, or eplerenone for treating hypokalemia in Gitelman syndrome.
17804670 2007. Mechanism of hypokalemia in magnesium deficiency.
15339977 2004. Altered renal distal tubule structure and renal Na(+) and Ca(2+) handling in a mouse model for Gitelman's syndrome.
10073595 1999. Dietary magnesium, not calcium, regulates renal thiazide receptor.
27466368 2016. Aldosterone Upregulates Transient Receptor Potential Melastatin 7 (TRPM7).
15234985 2004. A novel pathway of epithelial sodium channel activation involves a serum- and glucocorticoid-inducible kinase consensus motif in the C terminus of the channel's alpha-subunit.
4371752 1974. The vasopressin-sensitive adenylate cyclase of the rat kidney. Effect of adrenalectomy and corticosteroids on hormonal receptor-enzyme coupling.
18806605 2008. Causes and consequences of zinc dyshomeostasis in rats with chronic aldosteronism.
21214724 2011. Treatment considerations with aldosterone receptor antagonists.
16470083 2006. Aldosterone--a hormone of cardiovascular adaptation and maladaptation.
2830316 1988. Modulation of Na-K-ATPase activity in the mouse medullary thick ascending limb of Henle. Effects of mineralocorticoids and sodium.
2936762 1986. Blood levels and renal effects of atrial natriuretic peptide in normal man.
2995442 1985. Renal adaptation to potassium in the adrenalectomized rabbit. Role of distal tubular sodium-potassium adenosine triphosphatase.
12074739 2002. Muscle strength, Na,K-pumps, magnesium and potassium in patients with alcoholic liver cirrhosis -- relation to spironolactone.
30558036 2018. Aldosteronism with mild hypokalemia presenting as life-threatening ventricular arrhythmias: A case report.
25376771 2014. On the pleotropic actions of mineralocorticoids.
27234911 2017. Genetic causes of hypomagnesemia, a clinical overview.
21503667 2011. Bartter- and Gitelman-like syndromes: salt-losing tubulopathies with loop or DCT defects.
33200256 2021. Deletion of the transcription factor Prox-1 specifically in the renal distal convoluted tubule causes hypomagnesemia via reduced expression of TRPM6 and NCC.
27878608 2017. Claudins in barrier and transport function-the kidney.
26089029 2015. Furosemide stimulation of parathormone in humans: role of the calcium-sensing receptor and the renin-angiotensin system.
11152754 2001. Magnesium transport in the renal distal convoluted tubule.
31506348 2019. The single-cell transcriptomic landscape of early human diabetic nephropathy.
6060709 1967. Adrenal infunces on calcium and magnesium homeostasis in sheep.
2748795 1989. The effect of an intravenous infusion of aldosterone upon magnesium metabolism in the sheep.
4543705 1973. The role of magnesium and substances promoting the transport of electrolytes.
581026 1978. Endocrine effects of lithium. III. Hypermagnesaemia and activation of the renin-aldosterone system.
484255 1979. Effects on muscle electrolytes of potassium and magnesium infusions, spironolactone medication and operation in a case of primary aldosteronism.
3461689 1986. Potassium-sparing diuretics.
3017056 1986. Intracellular electrolytes in cardiac failure.
6959477 1982. Effect of moduretic and aldactone on electrolytes in skeletal muscle in patients on long-term diuretic therapy.
6942638 1981. The effect of diuretics on lymphocyte magnesium and potassium.
4317710 1970. Bartter's syndrome. A report of four cases, including three in one sibship, with comparative histologic evaluation of the juxtaglomerular apparatuses and glomeruli.
6324540 1984. Potassium supplements or potassium-sparing agents.
8729691 1996. Effects of K+, Mg2+ deficiency and adrenal steroids on Na+, K(+)-pump concentration in skeletal muscle.
14169401 1964. ALDOSTERONE: ITS BIOCHEMISTRY AND PHYSIOLOGY.
7986964 1994. A dose-response study of orally administered torsemide in patients with ascites due to cirrhosis.
12422134 2002. Aldosterone: cardiovascular assault.
8074021 1994. Clinical relevance and management of the major electrolyte abnormalities in congestive heart failure: hyponatremia, hypokalemia, and hypomagnesemia.
4310622 1969. Cardiopulmonary resuscitation. II.
7503007 1995. Effects of adding spironolactone to an angiotensin-converting enzyme inhibitor in chronic congestive heart failure secondary to coronary artery disease.
2309624 1990. Interaction of diuretics and electrolytes in congestive heart failure.
2178375 1990. Interrelation of electrolytes and renin-angiotensin system in congestive heart failure.
2353669 1990. Relation of cardiovascular disease to potassium and magnesium deficiencies.
2353668 1990. Short- and long-term mechanisms of sudden cardiac death in congestive heart failure.
3414540 1988. Control of renal perfusion and function in congestive heart failure.
3524185 1986. Hypokalemia in thiazide-treated systemic hypertension.
3953430 1986. Short- and long-term treatment of mild to moderate hypertension with verapamil.
2866707 1985. Renin, calcium metabolism and the pathophysiologic basis of antihypertensive therapy.
31086 1978. Effectiveness of high-dose spironolactone therapy in patients with chronic liver disease and relatively refractory ascites.
2007001 1991. The effect of Ca and Mg supplementation and the role of the opioidergic system on the development of DOCA-salt hypertension.
2021448 1991. Suppressive effect of sulfate on the development of hypertension in DOCA-salt hypertensive rats.
2196065 1990. Effects of magnesium on changes in blood pressure and plasma aldosterone induced by angiotensin II.
9002538 1997. Hypokalemic metabolic alkalosis with hypomagnesuric hypermagnesemia and severe hypocalciuria: a new syndrome?
1585928 1992. Diltiazem enhances potassium disposal in subjects with end-stage renal disease.
3030096 1987. Correction of hypokalemia in Bartter's syndrome by enalapril.
2420173 1986. A Bartter's-like syndrome from capreomycin, and a similar gentamicin tubulopathy.
1387762 1992. Cellular calcium and magnesium metabolism in the pathophysiology and treatment of hypertension and related metabolic disorders.
3022585 1986. The renin-angiotensin-aldosterone complex.
7036739 1982. Diagnostic strategies in disorders of fluid, electrolyte and acid-base homeostasis.
7025624 1981. Correction of hypokalemia by magnesium repletion in familial hypokalemic alkalosis with tubulopathy.
1190259 1975. Hypomagnesemia due to renal disease of unknown etiology.
4263467 1972. The tissue effects of mineralocorticoids.
4879832 1968. Calcium and the kidney.
13275492 1955. Spontaneous hypopotassemia, hypomagnesemia, alkalosis and tetany due to hypersecretion of corticosterone-like mineralocorticoid.
16909053 2006. Preventing oxidative stress in rats with aldosteronism by calcitriol and dietary calcium and magnesium supplements.
10653441 2000. Diuretic complications.
24776766 2014. Clinical severity of Gitelman syndrome determined by serum magnesium.
9481438 1998. Studies on the pathogenesis of hypokalemia in Gitelman's syndrome: role of bicarbonaturia and hypomagnesemia.
8080005 1994. Correction of hypokalemia with antialdosterone therapy in Gitelman's syndrome.
10600938 1999. Insulin stimulates Mg2+ uptake in mouse distal convoluted tubule cells.
9486228 1998. Aldosterone potentiates hormone-stimulated Mg2+ uptake in distal convoluted tubule cells.
8944655 1996. Angiotensin II activation of Ca(2+)-permeant nonselective cation channels in rat adrenal glomerulosa cells.
2180320 1990. Potassium load prevents the decrease of GFR induced by captopril in sodium-depleted rats.
3322045 1987. Effect of cyclosporin on blood pressure and renin-aldosterone axis in rats.
2984945 1985. Glucocorticoid effects on Na-K-ATPase in rabbit nephron segments.
6326615 1984. Steroid regulation of Na+-K+-ATPase: differential sensitivities along the nephron.
6135349 1983. Changes in tubular basolateral membrane markers after chronic DOCA treatment.
6246813 1980. Renal potassium adaptation: Na-K-ATPase activity along the nephron after chronic potassium loading.
665773 1978. Magnesium metabolism in potassium-depleted rats.
5786732 1969. Renal handling of magnesium in the dog.
4231022 1968. Effect of aldosterone on liver mitochondria isolated from adrenalectomized rats.
34232746 2021. Diseases caused by mutations in the Na(+)/K(+) pump alpha1 gene ATP1A1.
4984985 1969. Imbalancing of hemic calcium, magnesium, potassium, and sodium by rations and by perenteral injections of ethylenediaminetetraacetate dipotassium salt, potassium chloride, and aldosterone inhibitor. Comparison of cattle held at 2,745 and at 1,372 meters elevation.
1456628 1992. Tubulopatia de Gitelman: deficit de transfer K/Mg.
3277491 1988. Calcium antagonists as a new treatment modality in hypertension.
7486807 1995. Renin-angiotensin-aldosterone and kallikrein investigations in a patient with resistant hypomagnesaemia due to Gitelman's syndrome.
8250506 1993. Successful treatment of short stature and delayed puberty in congenital magnesium-losing kidney.
10790593 2000. Aldosterone antagonists in hypertension and heart failure.
6303175 1983. Monovalent and divalent ions in vascular tissue.
10528423 1999. Magnesium and cardiovascular drugs: interactions and therapeutic role.

14608519 2003. Toward a broader understanding of aldosterone in congestive heart failure.
12563564 2002. The potential benefits of aldosterone antagonism in Type 2 diabetes mellitus.
22473073 2012. Effects of gum arabic (Acacia senegal) on renal function in diabetic mice.
34252449 2021. Specific disruption of calcineurin-signaling in the distal convoluted tubule impacts the transcriptome and proteome, and causes hypomagnesemia and metabolic acidosis.
6296522 1982. Thick ascending limb of Henle's loop.
23526071 2013. Additional antihypertensive effect of magnesium supplementation with an angiotensin II receptor blocker in hypomagnesemic rats.
26878252 2015. Hyperphosphatemia, hypocalcemia and increased serum potassium concentration as distinctive features of early hypomagnesemia in magnesium-deprived mice.
25644859 2014. Variations in serum magnesium and hormonal levels during incremental exercise.
20513641 2010. Magnesium deficiency and metabolic syndrome: stress and inflammation may reflect calcium activation.
31567942 2019. Clinical significance of serum magnesium levels in patients with heart failure with preserved ejection fraction.
14286599 1965. ALDOSTERONE AND THE METABOLISM OF MAGNESIUM AND OTHER MINERALS IN THE SHEEP.
33155789 2021. Does fludrocortisone treatment cause hypomagnesemia in children with primary adrenal insufficiency?
19538300 2009. Insights into driving forces and paracellular permeability from claudin-16 knockdown mouse.
4279600 1974. Mechanism of action of aldosterone with particular reference to (Na plus K)-ATPase.
5259575 1969. A familial disorder characterized by hypokalemia and hypomagnesemia.
5259571 1969. Influence of various nutrients and hormones on urinary divalent cation excretion.
6881920 1983. Influence of the thyroid and parathyroid glands on magnesium metabolism during mineralocorticoid treatment (DOCA + NaCl) in the rat.
1164148 1975. Un syndrome de bartter associant un hypercortisolisme, un diabete phosphore et magnesien et une tubulopathie d'origine familiale
3896183 1985. Hyporeninemic hypoaldosteronism. New associations.
1482262 1992. Etude in vitro du role de l'endothelium sur l'effet vasorelaxant du magnesium sur l'aorte de rat, soumis a une hypertension mineralocorticoide.
3099703 1986. Magnesium alimentaire et hypertension mineralocorticoide DOCA et NaCl chez le rat. Influence sur le metabolisme du sodium et du magnesium.
5755406 1968. L'effetto dell'aldosterone sull'escrezione urinaria dei cationi bivalenti dell'uomo.
11998428 2002. Alterations moleculaires primaires et troubles biologiques secondaires des syndromes de Bartter et de Gitelman.
4740227 1973. Klinische Prufung der subtoxischen Vollwirk-und Erhaltungsdosis von Digoxin unter dem Einfluaa von Spironolaktone. Untersuchungen an dekompensierten Herzkranken.
7417374 1980. Pathophysiologic responses of spontaneously hypertensive rats to arterial magnesium--aluminum wire implants.
5679349 1968. The local action of ammonium, calcium and magnesium on adrenocortical secretion.
214077 1978. Direct stimulation of human erythrocyte membrane (Na+ + k+)-mg ATPase activity in vitro by physiological concentrations of d-aldosterone.
14095768 1963. EXPERIMENTAL CARDIAC NECROSIS.
2541725 1989. Effects of glycyrrhizin and glycyrrhetinic acid on (Na+ + K+)-ATPase of renal basolateral membranes in vitro.
2837236 1988. (Na+ -K+)ATPase activity in erythrocyte membranes of spontaneously, one kidney-one wrapped, and deoxycorticosterone acetate--NaCl hypertensive rats.
159056 1979. A Na+-activated Mg2+-dependent renal adenosine triphosphatase (Na+-ATPase) sensitive to aldosterone.
4239801 1969. Experimental studies on the carbonic anhydrase activity. XII. Effect of adrenocorticosteroids on carbonic anhydrase and Na+-K+-activated adenosine triphosphatase from kidney of adrenalectomized mice and rats.
4244236 1969. Regulation of the (Na+ equals K+)-activated ATP hydrolyzing enzyme system in rat kidney. II. The effect of aldosterone on the activity in kidneys of adrenalectomized rats.
12046544 2002. Studies on hypokalemia induced by trimethyltin chloride.
10655971 1999. Time-course of the change in blood pressure level in magnesium-deficient Wistar rats.
9389897 1997. The effects of high oral magnesium supplementation on blood pressure, serum lipids and related variables in apparently healthy Japanese subjects.
2819023 1989. The effect of varying the sodium or potassium intake, or both, on magnesium status in the rat.
5651549 1968. Urinary magnesium excretion in surgical patients.
159108 1978. Evolution de quelques parametres du metabolisme du magnesium au cours du traitement mineralocorticoide (DOCA + chlorure de sodium) chez le rat.
146554 1977. Metabolisme calcique et hypertension mineralocorticoide: effets de la parathormone et de la thyrocalcitonine exogenes et des variations de l'apport en calcium et en magnesium.
14614522 2003. Potential beneficial as well as detrimental effects of chronic treatment with lisinopril and (or) spironolactone on isolated hearts following low-flow ischemia in normal and infarcted rats.
12117304 2002. Magnesium supplementation and deoxycorticosterone acetate--salt hypertension: effect on arterial mechanical properties and on activity of endothelin-1.
487270 1979. The effect of spironolactone on the arterial water, cation, and norepinephrine contents of control and 'one-kidney-one-clip' hypertensive dogs.
1201492 1975. Water, cations, and norepinephrine content of cardiovascular tissues of unilaterally nephrectomized dogs treated with deoxycorticosterone and NaCl.
4241855 1969. Sodium binding in the arterial wall.
7954549 1994. Comparative analysis of torasemide and furosemide in liver cirrhosis.
22373564 2013. Parathyroid hormone, a crucial mediator of pathologic cardiac remodeling in aldosteronism.
16631148 2006. Oxidative stress in aldosteronism.
14985063 2004. Review of aldosterone- and angiotensin II-induced target organ damage and prevention.
9015414 1996. Whey mineral supplementation and arterial tone in mineralocorticoid-NaCl hypertension.
6138150 1983. Effectiveness of antiarrhythmic agents in preventing death in ventricular fibrillation induced by isoprenaline in desoxycorticosterone-pretreated rats.
1623802 1992. The effects of enalapril and spironolactone on terbutaline-induced hypokalemia.
6263558 1981. Clinical chronopharmacology of ACTH 1-17. II. Effects on plasma testosterone, plasma aldosterone, plasma and urinary electrolytes (K, Na, Ca and Mg).
15591230 2005. Transient receptor potential melastatin 7 ion channels regulate magnesium homeostasis in vascular smooth muscle cells: role of angiotensin II.
1849057 1991. Na,K-ATPase in isolated nephron segments in rats with experimental heart failure.
15611366 2005. Aldosteronism and a proinflammatory vascular phenotype: role of Mg2+, Ca2+, and H2O2 in peripheral blood mononuclear cells.
15723988 2005. Calcium, magnesium, and oxidative stress in hyperaldosteronism.
15710759 2005. Hyperparathyroidism and the calcium paradox of aldosteronism.
2529059 1989. Low-dose infusion of atrial natriuretic factor in mild essential hypertension.
16272623 2005. Potassium and magnesium depletions in congestive heart failure--pathophysiology, consequences and replenishment.
15692156 2005. [Aldosterone and magnesium].
15692155 2005. [Magnesium in congestive heart failure].
21699555 2011. Mineralocorticoid antagonism: a novel way to treat sarcopenia and physical impairment in older people?
3002681 1985. Diagnosis and treatment of primary aldosteronism and isolated hypoaldosteronism.
7011604 1980. Neonatal endocrine and metabolic emergencies.
9764722 1998. Hypertension development in Dahl S and R rats on high salt-low potassium diet: calcium, magnesium and sympathetic nervous system.
8556001 1995. Dietary L-arginine attenuates blood pressure in mineralocorticoid-salt hypertensive rats.
2743585 1989. Decreased cytosolic free calcium concentration in lymphocytes of magnesium-supplemented DOCA-salt hypertensive rats.
2832105 1988. Effects of thiazide on erythrocyte sodium and potassium concentrations and Na+K+ATPase in hypertensive patients.
3581484 1987. Production and reversal of DOCA-salt hypertension in baboons.
6136351 1983. Erythrocyte membrane abnormalities in hypertension: a comparison between two animal models.
8374255 1993. Torasemide versus furosemide in cirrhosis: a long-term, double-blind, randomized clinical study.
12141411 2002. Successful treatment by cyclooxyenase-2 inhibitor of refractory hypokalemia in a patient with Gitelman's syndrome.
7075119 1982. Amiloride in Bartter's syndrome.
3208481 1988. Aldosterone and magnesium in essential arterial hypertension.
1655330 1991. Plasma and tissue kallikrein-kinin systems during acute administration of frusemide in normotensive and hypertensive humans.
3311571 1987. Effects of a single moderate dose of alcohol on blood pressure, heart rate and associated metabolic and endocrine changes.
4359750 1974. Effects of angiotensin on plasma electrolyte concentrations in rabbits and in man.
2880664 1986. Spironolactone in the management of congestive cardiac failure: a review.
620515 1978. Potassium-level changes during long-term thiazide therapy.
16036025 2004. Efficacy of aldosterone receptor antagonism in heart failure: potential mechanisms.
10995520 2000. Spironolactone in congestive heart failure.
24786834 2014. Effect of canagliflozin on serum electrolytes in patients with type 2 diabetes in relation to estimated glomerular filtration rate (eGFR).
6499698 1984. Intracellular magnesium loss after diuretic administration.
6389078 1984. Endocrine physiology of electrolyte metabolism.
263095 1979. Serum calcium, magnesium and phosphate in bilharzial hepatic fibrosis.
3549258 1987. Reduced glomerular angiotensin II receptor density in diabetes mellitus in the rat: time course and mechanism.
6023564 1967. Aldosterone secretion in magnesium-deficient rats.
1212990 1975. Ultrastructural changes of the hypothalamo-hypophysial neurosecretory system in the magnesium deficient rats.
8682054 1995. Aldosterone escape during ACE inhibitor therapy in chronic heart failure.
3886375 1985. Urinary excretion of electrolytes during prolonged physical activity in normal man.
8721414 1996. Ionised and total magnesium serum concentrations in renal and hepatic diseases.
3402518 1988. The effect of diuretic therapy on adrenaline-induced hypokalaemia and hypomagnesaemia.
3758141 1986. Effects of spironolactone on serum and muscle electrolytes in patients on long-term diuretic therapy for congestive heart failure and/or arterial hypertension.
15223177 2004. Maternal Bartter's syndrome in pregnancy treated by amiloride.
8088352 1994. Influence of endothelium on Mg(2+)-induced relaxation in noradrenaline-contracted aorta from DOCA-salt hypertensive rat.
2524398 1989. Direct binding of atrial natriuretic factor to adrenocortical mitochondria.
4108041 1971. Electron microscopy of a microsomal fraction ritch in (Na++K+)-ATPase and isolated from kidney cortex. Structural changes accompanying freeze- and DOC-activation and identification of main components.
16366159 2005. Cardioprotection by aldosterone receptor antagonism in heart failure. Part I. The role of aldosterone in heart failure.
6706271 1984. Untersuchungen zur Elektrolyt-Ausscheidung nach Gabe verschiedener Diuretika bei gesunden Frauen.
2976727 1988. Hemodynamic, renal, and endocrine effects of 4-h infusions of human atrial natriuretic peptide in normal volunteers.
8199766 1994. Prevention of hypokalemia caused by diuretics.
4636278 1972. Acute effect of aldosterone on tubular calcium and magnesium reabsorption.
14689103 2003. A neuroendocrine-immune interface. The immunostimulatory state of aldosteronism.
3549504 1987. Acute changes in plasma renin activity, plasma aldosterone concentration and plasma electrolyte concentrations following furosemide administration in patients with congestive heart failure--interrelationships and diuretic response.
447212 1979. Effect of progesterone on serum and tissue electrolyte concentration in doca-treated rats.
5527947 1970. Effect of adrenal and parathyroid on electrolyte excretion in rat.
6489931 1984. Effect of aldosterone on the serum zinc, copper, and magnesium concentrations in the rat.
20827279 2010. From aldosteronism to oxidative stress: the role of excessive intracellular calcium accumulation.
18268139 2008. Downregulation of renal TRPM7 and increased inflammation and fibrosis in aldosterone-infused mice: effects of magnesium.
14638620 2004. Low [Mg2+]e enhances arterial spontaneous tone via phosphatidylinositol 3-kinase in DOCA-salt hypertension.
12154101 2002. Mineralocorticoid and angiotensin receptor antagonism during hyperaldosteronemia.
10642284 2000. Intralymphocyte free magnesium in patients with primary aldosteronism: aldosterone and lymphocyte magnesium homeostasis.
8349327 1993. Salt-dependent renal effects of an angiotensin II antagonist in healthy subjects.
8225532 1993. Natriuretic and hypotensive effect of adenosine-1 blockade in essential hypertension.
8505087 1993. Magnesium deficiency produces insulin resistance and increased thromboxane synthesis.
2298478 1990. Dietary linoleic acid prevents the development of deoxycorticosterone acetate-salt hypertension.
2966770 1988. Atrial natriuretic factor in mild to moderate chronic renal failure.
3770872 1986. Systemic and renal vascular responses to dietary calcium and vitamin D.
6998872 1980. Clinical and biochemical effects of spironolactone administered once daily in primary hypertension. Multicenter Sweden study.
15310530 2004. Fiftieth anniversary of aldosterone: from discovery to cardiovascular therapy.

8894790 1996. Effects of magnesium on blood pressure and intracellular ion levels of Brazilian hypertensive patients.
17886090 2008. Sodium-bicarbonated mineral water decreases aldosterone levels without affecting urinary excretion of bone minerals.
330442 1977. Plasma aldosterone and magnesium in serum and urine during lithium treatment.
5788681 1969. Einfluss von Aldosteron auf den Interflux und Efflux arbeitsmedizinisch relevanter Mineralien und Spurenelemente des menschlichen Organismus.
4365784 1974. Primarer Hypo- und Hyperreninismus
7107204 1982. Relationship of bone and plasma magnesium in magnesium-deficient cirrhosis patients.
7185847 1982. Magnesium treatment of diuretic-induced hyponatremia with a preliminary report of a new aldosterone-antagonist.
12115072 2002. Spironolactone for the treatment of hypercalciuric hypocalcemia.
17448413 2007. Spironolactone reduced arrhythmia and maintained magnesium homeostasis in patients with congestive heart failure.
8798105 1996. Aldosterone escape during angiotensin-converting enzyme inhibitor therapy in chronic heart failure.
1339793 1992. [The relation of physical and mental stress to magnesium deficiency in patients with variant angina].
12950527 2003. Use of nonantiarrhythmic drugs for prevention of sudden cardiac death.
12827022 2003. Effect of magnesium on mRNA expression and production of endothelin-1 in DOCA-salt hypertensive rats.
8847860 1996. Cell membrane cation transport systems during aldosterone antagonism.
1691374 1990. Intravascular and interstitial fluid dynamics in rats treated with minoxidil.
2474099 1989. Loop diuretics combined with an ACE inhibitor for treatment of hypertension: a study with furosemide, piretanide, and ramipril in spontaneously hypertensive rats.
2473355 1989. Atrial natriuretic factor administered to humans: 1984-1988.
2580178 1985. Effects of captopril, hydrochlorothiazide, and their combination on timed urinary excretions of water and solutes.
31162549 2019. The Effects of Dapagliflozin on Systemic and Renal Vascular Function Display an Epigenetic Signature.
2965159 1988. Low dose infusions of 26- and 28-amino acid human atrial natriuretic peptides in normal man.
2973471 1988. Atrial natriuretic hormone has biological effects in man at physiological plasma concentrations.
2943757 1986. Renal, hemodynamic, and hormonal responses to atrial natriuretic peptide infusions in normal man, and effect of sodium intake.
13964048 1962. Effect of aldosterone on the metabolism of magnesium.
13587636 1958. Divergence in magnesium, sodium and potassium excretion during stimulation of endogenous aldosterone production.
3021923 1986. Increased plasma renin and aldosterone in patients treated with cisplatin-based chemotherapy for metastatic germ-cell tumors.
2050832 1991. Hydrochlorothiazide versus spironolactone: long-term metabolic modifications in patients with essential hypertension.
33068771 2021. Fetal ventricular tachycardia: betablockers should be the first line treatment.
7473525 1995. Mineralocorticoid receptor blockade in chronic heart failure.
2547951 1989. An association between mineral metabolism and the renin-aldosterone system in human hypertension.
21602712 2011. Dysregulation of renal transient receptor potential melastatin 6/7 but not paracellin-1 in aldosterone-induced hypertension and kidney damage in a model of hereditary hypomagnesemia.
11204298 2001. Effect of oral magnesium supplementation on blood pressure, platelet aggregation and calcium handling in deoxycorticosterone acetate-induced hypertension in rats.
10930190 2000. Effect of oral magnesium supplementation on blood pressure, platelet aggregation and calcium handling in deoxycorticosterone acetate induced hypertension in rats.
11132614 2000. Effect of oral magnesium supplementation on blood pressure in deoxycorticosterone acetate-induced hypertension in rats.
1655884 1991. Altered cations and muscle membrane ATPase activity in deoxycorticosterone acetate-salt spontaneously hypertensive rats.
3385207 1988. Haemodynamic response to magnesium administration in mineralocorticoid-salt and two-kidney, one clip renovascular hypertension.
6681043 1983. Membrane abnormalities occur in vascular smooth muscle but not in non-vascular smooth muscle from rats with deoxycorticosterone-salt induced hypertension.
1818978 1991. Time-course of changes in intracellular cations and blood pressure with salt loading in patients with essential hypertension.
3537234 1986. Electrolytes and spontaneous genetic hypertension in rats.
3553472 1986. Effects of altered dietary calcium intake in experimental hypertension: role of intracellular free magnesium.
2341751 1990. Disturbance of the water and electrolyte balance during high-dose interferon treatment.
16099237 2005. Responses in extracellular and intracellular calcium and magnesium in aldosteronism.
12960953 2003. Aldosteronism revisited: perspectives on less well-recognized actions of aldosterone.
8228558 1993. Effects of magnesium on the renin-angiotensin-aldosterone system in human subjects.
6413630 1983. Natural history of potassium-deficiency myopathy in the dog: role of adrenocorticosteroid in rhabdomyolysis.
1123557 1975. Pathophysiology of angiotensin-salt hypertension.
6052959 1967. The acute effect of adrenal steroids on the interrelationship between the renal excretion of sodium, calcium, and magnesium.
27423273 2016. Metformin inhibits aldosterone-induced cardiac fibroblast activation, migration and proliferation in vitro, and reverses aldosterone+salt-induced cardiac fibrosis in vivo.
21964566 2012. Antihypertensive effect of Melothria maderaspatana leaf fractions on DOCA-salt-induced hypertensive rats and identification of compounds by GC-MS analysis.
7722684 1995. Dietary magnesium supplementation modifies blood pressure and cardiovascular function in mineralocorticoid-salt hypertensive rats but not in normotensive rats.
3083056 1986. Alterations in electrolyte and iron metabolism in the rat in relation to peroral administration of galactitol, mannitol and xylitol.
1245942 1976. Asymptomatic chronic hypomagnesemia and hypokalemia in a child: Cell membrane disease.
5413668 1970. Serum magnesium in children with cirrhosis.
4932990 1971. Effect of lithium salts on electrolyte metabolism.
2527325 1989. Further studies on the effect of aldosterone on Mg2+-HCO3(-)-ATPase and carbonic anhydrase from rat intestinal mucosa.
2826910 1987. Glycyrrhizic acid and its hydrolysate as mineralocorticoid agonist.
3160893 1985. Effect of aldosterone antagonists on aldosterone-induced activation of Mg2+ -HCO3- -ATPase and carbonic anhydrase in rat intestinal mucosa.
6139508 1983. Brush border Mg2+-HCO-3-ATPase, supernatant carbonic anhydrase and other enzyme activities isolated from rat intestinal mucosa: effect of adrenalectomy and aldosterone administration.
6117675 1981. Carbonic anhydrase, Mg2+-HCO-3-ATPase and Mg2+-Na+-K+-ATPase in rat intestinal mucosa: effects of adrenalectomy and aldosterone administration.
4265529 1972. The role of aldosterone in the regulation of (Na + + K + )-ATPase in rat kidney.
20569932 2010. Antihypertensive effect of Cu and Mg enriched modified poultry eggPsi on Zn-induced hypertension in Wistar rat.
17983885 2007. Influence of combined angiotensin-converting enzyme inhibitors and spironolactone on serum K+, Mg 2+, and Na+ concentrations in small dogs with degenerative mitral valve disease.
34791658 2021. Safety of torasemide in healthy adult dogs administered daily for 26 weeks.
1338597 1992. Effects of dietary magnesium supplementation on diurnal variations of blood pressure and plasma Na+, K(+)-ATPase activity in essential hypertension.
1177408 1975. Changes of fractional renal clearance of magnesium after spironolactone administration in normal subjects.
5383802 1969. Das Verhalten des Serum-Magnesiums bei experimenteller Hyperthyreose und bei gleichzeitiger Anwendung eines Aldosteron-Antagonisten.
5992810 1966. Beitrag zur Klinik und Biochemie des primaren Hyperaldosteronismus.
10972386 2000. Hypertensive emergencies.
2857901 1985. Renal, haemodynamic, and hormonal effects of human alpha atrial natriuretic peptide in healthy volunteers.
14399532 1960. The influence of aldosterone on magnesium metabolism.
2023523 1991. Effects of ethinyl estradiol on isoproterenol-induced death in ventricular fibrillation in DOCA-salt pretreated male and female rats.
2542710 1989. Magnesium ion: a possible physiological regulator of aldosterone production.
6621246 1983. Death in ventricular fibrillation induced by isoproterenol in DOCA-salt pretreated rats preceded by changes in myocardial electrolytes.
1196006 1975. The effect of magnesium deficiency on serum aldosterone in rats fed two levels of sodium.
14326244 1965. EFFECT OF ADRENAL SEOIDS ON A NA+ K+ DEPENDENT ADENOSINE TRIPHOSPHATASE.
10612086 1999. Platelet magnesium depletion in normotensive and hypertensive obese subjects: the role of salt-regulating hormones and catecholamines.
9513926 1997. Magnesium modulates ouabain action on angiotensin II-induced aldosterone synthesis in vitro.
1296760 1992. Influence of endothelium in the in vitro vasorelaxant effect of magnesium on aortic basal tension in DOCA-salt hypertensive rat.
3079422 1988. High serum magnesium and the renin-aldosterone axis: a personal analysis.
2515398 1989. Mechanisms of blood pressure regulation by magnesium in man.
3626625 1987. Systemic and regional hemodynamic effect of acute magnesium administration in the normotensive and hypertensive state.
3543514 1986. Magnesium and potassium-sparing diuretics.
4033201 1985. Magnesium and liver cirrhosis: a hypothesis.
6536838 1984. Potassium deficiency and cardiac function: experimental and clinical aspects.
6536835 1984. Mode of action of conventional and potassium-sparing diuretics--aspects with relevance to Mg-sparing effects. Review of the present state of the art and recent findings.
6503360 1984. Effects of desoxycorticosterone acetate on magnesium metabolism in potassium-depleted rats.
192954 1977. The role of the adrenal cortex in human essential hypertension: keynote address.
1143129 1975. Some aspects of diuretic therapy.
5792705 1969. The effect of prolonged intravenous infusion of aldosterone in a normal human subject.
5684790 1968. Effect of prolonged administration of aldosterone on potassium and magnesium metabolism in the rabbit.
492054 1979. Plasmaaldosteron und Elektrolyte beim primaren und sekundaren Hyperaldosteronismus.
24095631 2014. Aldosterone and parathyroid hormone interactions as mediators of metabolic and cardiovascular disease.
12500432 2002. Gateways to clinical trials.
7902890 1993. Erythrocyte and platelet cationic concentrations and transport systems in normal volunteers treated with carmoxirole.
1507935 1992. Heart failure and electrolyte disturbances.
8377729 1993. Attenuation by spironolactone of the magnesiuric effect of acute frusemide administration in patients with liver cirrhosis and ascites.
12537991 2003. Magnesium and heart failure.
11026567 2000. The paradoxical effect of adrenomedullin on Na+ transport by the renal distal tubule luminal membrane.
2843743 1988. Do canrenone and 6,7-dihydroxylated derivatives compete with ouabain at the same site on Na,K-ATPase?
4270736 1973. Extrarenal effects of aldosterone antagonists in guinea pigs. I. Enhanced transport of potassium into the cells.
12401934 2002. Bartter's, Gitelman's, and Gordon's syndromes. From physiology to molecular biology and back, yet still some unanswered questions.
11015018 2000. Aldosterone influences serum magnesium in Gitelman syndrome.
8856296 1996. Effects of the intravenous magnesium administration on aldosterone and atrial natriuretic factor plasma concentrations.
450167 1979. Symptomatic hypomagnesemia associated with gentamicin therapy.
1101088 1975. Kidney and adrenocortical hormones.
5438899 1970. Studies of the acute effects of aldosterone and cortisol on the interrelationship between renal sodium, calcium and magnesium excretion in normal man.
7892033 1994. Effects of dietary magnesium on blood pressure and vascular lesions in hypertensive rats.
26178649 2016. Pathophysiology and clinical presentations of salt-losing tubulopathies.
12163983 2002. Oral Mg(2+) supplementation reverses age-related neuroendocrine and sleep EEG changes in humans.
4901030 1969. Endocrine control of calcium and magnesium metabolism in ruminants.
7323077 1981. Mechanism of negative potassium balance in the magnesium-deficient rat.
684008 1978. Amelioration of nutritional secondary hyperparathyroidism in rats by adrenalectomy.
4349975 1973. Effect of adrenal arterial infusion of different Mg 2+ concentrations on the spontaneous release of catecholamines in the anesthetized dog.
5138436 1971. Requirement of the adrenal for certain urine electrolyte effects of salmon calcitonin in rats.
3628341 1987. Circannual variations in blood pressure, urinary catecholamine excretion, plasma aldosterone, and serum sodium, potassium, calcium, and magnesium in children 11 +/- 1.5 years of age.
1475272 1992. In vivo and in vitro magnesium effects on aortic prostacyclin generation in DOCA-salt hypertensive rats.
14241358 1964. CHANGES OF THE MAGNESIUM CONTENT OF THE SERUM FOLLOWING ACTH LOADS IN PATIENTS SUFFERING FROM MULTIPLE SCLEROSIS.
7146310 1982. Bartter's syndrome--observations on the pathophysiology.
2669068 1989. Antidiuretic hormone regulation of electrolyte transport in the distal nephron.
4438846 1974. Zur Beeinflussung des Magnesiumstoffwechsels bei der Ratte wahrend experimenteller Hyperthyreose
5055006 1972. Zur Beeinflussung der Aldosteronsekretion des Hundes durch veranderte Plasma-Magnesium-Konzentration.
5135405 1971. Effect d'antikaliuretiques dans le developpement des lesions cardiaques chez le rat deficient en potassium ou en magnesium.
5162648 1971. Acute effect of aldosterone on cardiovascular tissues of dogs.
4768302 1973. Muscle electrolytes and total exchangeable electrolytes in patients with cardiac diseases.
16173138 2005. Magnesium supplementation and muscle function in patients with alcoholic liver disease: a randomized, placebo-controlled trial.
5929460 1966. A new familial disorder characterized by hypokalemia and hypomagnesemia.
20970606 2010. Changes in magnesium and potassium homeostasis after conversion from a calcineurin inhibitor regimen to an mTOR inhibitor-based regimen.
5155966 1971. Tierexperimentelle untersuchungen an Hunden zur Beeinflussung der Aldosteronsekretion durch veranderte Plasma-Magnesiumkonzentration.
5401672 1969. Untersuchungen zur Wirkung verschiedener Diuretika und Aldosteronantagonisten auf die renale Magnesiumausscheidun.
25257351 2014. The influence of enalapril and spironolactone on electrolyte concentrations in Doberman pinschers with dilated cardiomyopathy.
30678852 2019. Aldosterone and Ion Channels.
25754753 2015. Molecular pathophysiology of Bartter's and Gitelman's syndromes.
5605210 1967. Die hormonelle Regulation der Magnesium-Verteilung.
16563245 2005. [Effects of carvedilol on neurohormone and magnesium metabolism in patients with chronic heart failure].